Dr Reddy's Laboratories Ltd.

Dr Reddy's Laboratories Ltd.

Dr Reddy's Laboratories Ltd.

Overview
Date Founded

1984

Headquarters

Door No. 8-2-337,Road No. 3,Banjara Hills,Hyderabad, Telangana 500034

Type of Company

Public

Employees (Worldwide)

21.6K

Industries

Pharmaceuticals
Biotechnology
Hospitals & Patient Services
Medical Support Services
Wholesale: Consumer Non-Durables/Sundries

Company Description

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API or bulk drugs, which are principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research, development, and manufacture of differentiated formulations and new chemical entities. The Others segment includes the operations of the wholly-owned subsidiary of the company, Aurigene Discovery Technologies Limited, a discovery stage biotechnology company developing novel and best-in-class therapies in the fields of oncology and inflammation and which works with pharmaceutical and biotechnology companies in early-stage collaborations, brining drug candidates for pre-clinical development. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Contact Data
Trying to get in touch with decision makers at Dr Reddy's Laboratories Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Executive Officer

Chief Financial Officer

Chief Executive Officer, Branded Markets India & Emerging Countries

Chief Executive Officer, European Generics

Chief Executive Officer, North America Generics

Chief Human Resource Officer

Global Head of Quality

Vice President & Head, External R&D & Global Marketing

Global Head of Supply Chain

Board of Directors

Chief Executive Officer at Dr. Reddy's Laboratories, Inc.

Former Chief Executive Officer at Dr Reddy's Laboratories Ltd.

Industry Advisor at KKR India LLC

Chairman, South & Southeast Asian Operations at JPMorgan Chase & Co.

President at TiE Silicon Valley

Former Executive Chairman at Infectious Disease Research Institute

Chairman-South & Southeast Asian Operations at JPMorgan Chase & Co.

Former Managing Director at Tata Chemicals Ltd.

Former President & Chief Executive Officer at Teva Pharmaceutical Industries Ltd.

Paths to Dr Reddy's Laboratories Ltd.
Potential Connections via
Relationship Science
You
Dr Reddy's Laboratories Ltd.
Owners & Shareholders
Details Hidden

First Sentier Investors (formerly Colonial First State Global Asset Management) is a global asset management group focused on providing high quality, long-term investment capabilities to clients. We bring together independent teams of active, specialist investors who share a common commitment to responsible investment principles.

Details Hidden

SBI is an active manager which offers portfolios that focuses on Indian securities. Portfolios offered in SBI separately managed accounts may be suitable for a wide variety of investors, but particularly for more conservative investors with long-term time horizons that seeks growth of capital or a high level of current income, investments in sound, well-managed companies that have long-term potential investments gains, and those who wish not to be led by the market’s irrational and emotional behavior and desire an easy-to- understand strategy for investing in the stock and bond markets. The firm may also purchase, recommend and provide advice on investment in fixed rate instruments, foreign securities (particularly Indian securities), money market and other financial instruments, derivative and hybrid instruments and any other interest in any of the foregoing.

Details Hidden

RBC GAM-UK employs fundamental analysis and quantitative analysis. Individual portfolio managers may emphasize one method of security analysis over another in providing investment management services to discretionary clients and recommendations to nondiscretionary clients. The firm’s investment teams are responsible for researching investment opportunities, and implementing their findings and views on specific issuers in the management of clients’ portfolios. RBC GAM-UK employs various investment strategies through our investment mandates that are based on the objectives and strategies of the clients involved.

Recent Transactions
Details Hidden

Dr Reddy's Laboratories Ltd. purchases Wockhardt Ltd. /Domestic Formulations Bus from Wockhardt Ltd.

Details Hidden

Genomma Lab Internacional SAB de CV, Genomma Lab USA, Inc. purchase Dr. Reddy's Laboratories Ltd. /Bufferin Brand from Dr Reddy's Laboratories Ltd.

Details Hidden

Dr Reddy's Laboratories Ltd. purchases Imperial Credit Pvt. Ltd.

Transaction Advisors
Investment Advisor

Advised onDr Reddy's Laboratories Ltd. purchases OctoPlus NV

Accountant

Advised onStumpp Schuele & Somappa Ltd purchases Compact Electric Ltd from Dr Reddy's Laboratories Ltd.

Underwriter

Advised onDr Reddy's Laboratories Ltd. issued USD American Depositary Shares (ADS)

Advisors & Consultants
Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Advisor

Former President & Chief Financial Officer at Dr Reddy's Laboratories Ltd.

Clients

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Exelixis is a biopharmaceutical company committed to developing and commercializing small molecule therapies for the treatment of cancer. In advancing our first product, COMETRIQ, from discovery to market, we have established an effective and integrated infrastructure that encompasses the entire biopharmaceutical development continuum. We are committed to excellence in all aspects of our work and are dedicated to improving the care and outcome of cancer patients.

Encore Dermatology, Inc. manufactures prescription therapies and medical devices for dermatologists. It offers hylatopicplus emollient foam, hylatopicplus cream, and tetrix cream to manage and relieve the burning, itching, and pain. The company was founded Robert J. Moccia and Michael Brown in 2015 and is headquartered in Malvern, PA.

Key Stats and Financials As of 2020
Market Capitalization
$12.1B
Total Enterprise Value
$6.8B
Earnings Per Share
$1.55
EBITDAMargin
23.54%
Three Year Compounded Annual Growth Rate Of Revenue
7.43%
Debt TEV
0.04x
TEVNet Income
26.36x
Enterprise Value EBITDAOperating
12.5x
Enterprise Value / Sales
2.94x
Revenue
$2.31B
EBITDA
$543M
Total Debt
$292M
Total Equity
$2.05B
Net Profit
$258M
Investments
Details Hidden

Perlecan Pharma Pvt Ltd. provides research and development for new drugs. The company is headquartered in Hyderabad, India

Suppliers
NATCO Pharma Ltd. Hospitals & Patient Services | Hyderabad, India

NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.

Ess Dee Aluminium Ltd. Paper Products | Mumbai, India

Ess Dee Aluminium Ltd. is a holding company, which engages in the manufacture of packaging materials for pharmaceutical, food, and fast-moving consumer goods industries. It specializes in cold form blister and child-resistant-blister packaging. The company was founded in 1991 and is headquartered in Mumbai, India.

HSIL Ltd. Industrial Machinery & Manufacturing | Gurgaon, India

HSIL Ltd. engages in the manufacture, sale and trading of glass, building, plastic and consumer products. It operates through the following segments: Building Products, Consumer Products, Packaging Products, Retail Business and Others. The company was founded on February 8, 1960 and is headquartered in Gurgaon, India.

Competitors
Perrigo Co. Plc Pharmaceuticals - Dublin, Ireland

Perrigo Co. Plc engages in the provision of over-the-counter (OTC) self-care and wellness solutions. It operates through the following segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment includes the OTC, infant formula, and oral self-care categories; divested animal health category; and contract manufacturing businesses in the U.S., Mexico, and Canada. The Consumer Self-Care International segment consists of the consumer self-care business primarily branded in Europe and Australia; store brand business in the United Kingdom and parts of Europe and Asia; and divested liquid licensed products business in the United Kingdom. The Prescription Pharmaceuticals segment commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

Sun Pharmaceutical Industries Ltd. Pharmaceuticals - Mumbai, India

Sun Pharmaceutical We are an international speciality pharma company, with a large presence in the US and India, and a footprint across 41 other markets. In the US, which is our largest market, we have built a strong pipeline of generics, directly and through our subsidiaries Caraco and Sun Pharmaceutical Inc. Taro adds strong dermatology range to this portfolio. In India and rest of the world markets, our brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, diabetology, ophthalmology, orthopedics etc. We are market leaders in speciality therapy areas in India. We retain the drive for growth that marked our early days, when we had. begun in 1983 with just 5 products. Since then, we have crossed several milestones to emerge as a leading pharma company in India where we are the 5th largest by prescription sales, a rank that we have retained over a decade. (IMS ORG Stockist Audit, March. 2012) Since the mid- nineties, we have used a combination of growth and acquisition to drive growth. important acquisitions have included those of the US, detroit-based Caraco Parma Labs and a plant at Halol which now holds UKMHRA and USFDA approvals. The 2010 acquisition of Taro Pharmaceuticals doubles our US business and brings us strengths in dermatology and pediatrics

Aurobindo Pharma Ltd. Pharmaceuticals - Hyderabad, India

Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dr Reddy's Laboratories Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dr Reddy's Laboratories Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Dr Reddy's Laboratories Ltd..